India to United Kingdom: Cetuximab Export Trade Route

The India to United Kingdom Cetuximab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $131.1K USD. The route is dominated by BILCARE LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's cetuximab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $32.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with cetuximab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 19.9%, placing it at rank #1 among India's top cetuximab export destinations globally.

On the import side, key buyers of Indian cetuximab in United Kingdom include AERONA CLINICAL LIMITED, THE PURCHASE MANAGE R HEALTH CITY CAYMAN ISLAND LIMITED, THE PURCHASE MANAGE R HEALTH CITY CAVMAN ISLAND LTD. AERONA CLINICAL LIMITED is the single largest importer with 1 shipments valued at $118.5K USD.

India's cetuximab exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. BILCARE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BILCARE LIMITED, MILES INTERNATIONAL — together account for 100% of total trade value on this route. The average shipment value of $32.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as [tax document no. thc000019; gstin. 27aanft3310m1zw] cetuximab injection erbitux 500mg and [tax document no. thc000017; gstin. 27aanft3310m1zw] cetuximab injection 500mg erbitux 500, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AERONA CLINICAL LIMITED is the largest importer with 1 shipments worth $118.5K USD — representing 90% of all cetuximab imports from India on this route.